期刊文献+

紫外分光光度法测定复方补骨质缓释片中补骨脂总黄酮的含量 被引量:6

Determination of the Content of Total Flavonoid in Fufang Psoralen Corylifolia Sustained-release Tablets by Ultraviolet Spectrophotometry
原文传递
导出
摘要 目的:建立以紫外分光光度法测定复方补骨质缓释片中补骨脂总黄酮含量的方法。方法:以补骨脂甲素为对照品,氢氧化钠为显色剂,测定波长为440nm。结果:在4.10~12.30μg.mL-1浓度范围内补骨脂甲素的吸收度与浓度线性关系良好(r=0.9998),平均回收率为100.5%(RSD=1.57%,n=9)。结论:本方法操作简便、灵敏度高、重现性好,能准确测定复方补骨质缓释片中补骨脂总黄酮的含量。 OBJECTIVE: To establish a method for the determination of the content of total Flavonoid in Fructus Psoraleae by UV spectrophotometry. METHODS: The determination was performed using Bavachin standard as control substance, and sodium hydroxide as color- developing agent, with the wavelength set at 440nm. RESULTS. The absorbency and concentration of Bavachin have good linearity in the range of 4.10-12.30μg · mL^ -1( r = 0.999 8). The average recovery rate was 100.5% (RSD = 1.57%, n = 9). CONCLUSION: The method is easy to operate, highly accurate, reproducible and can be applied to determine the content of total Flavonoid in Fufang Psoralen corylifolia sustained - release tablets.
出处 《中国药房》 CAS CSCD 北大核心 2007年第9期673-674,共2页 China Pharmacy
基金 重庆市科委资助攻关项目(2005AD5020)
关键词 紫外分光光度法 复方补骨质缓释片 补骨脂总黄酮 含量测定 UV spectrophotometry Fufang Psoralen corylifolia sustained- release tablets Total Flavonoid in Fructus Psoraleae Content determination
  • 相关文献

参考文献1

二级参考文献2

共引文献27

同被引文献24

  • 1郑柏勤,朱惠洪,梁文权.不同来源的花生壳总黄酮含量测定研究[J].现代食品与药品杂志,2006,16(6):1-3. 被引量:10
  • 2周红燕,陈建伟.紫外分光光度法测定炒决明子中总蒽醌含量[J].天津中医药,2007,24(2):156-158. 被引量:16
  • 3贵州省食品药品监督管理局.贵州省中药材、民族药材质量标准[S].贵阳:贵州科技出版社,2003.
  • 4Huang YT, Cheng C J, Lai TF, et al. An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatmentdrug) sustained-release pellets by microdialysis Technique in the rabbit model [J]. Neuroscience Letters, 2007,416(3) : 302.
  • 5Zhao B, MoochhalaSM, Lu J, et al. Determination of pyfidostigmine bromide and its metabolites in biological samples [J]. J Pharm Sci, 2006,9( 11 ) : 71.
  • 6Lamproglou L, Barbier L, Diserbo M, et al. Repeated stress in combination with pyridostigmine: Part I: Long-term behavioural consequences [J]. Behavioural Brain Research, 2009,197(2): 301.
  • 7Haigh JR, Adler M, Apland JP, et al. Protection by pyridostigrnine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure[J]. Chemico-Biological Interactions, 2010, 187 ( 1-30 ) : 416.
  • 8Vidal AT, Guimaraes HN, Paula DC, et al. Prolonged cardioprotective effect of pyridostigmine encapsulated in liposomes [J]. Life Sciences, 2010, 86 (1-2):17.
  • 9中华人民共和国卫生部.脉舒胶囊-卫生部药品标准-中药成方制剂(第12册)[S].WS3-B-2 390,1997.
  • 10云南省卫生厅编.花生壳-云南省药品标准[M].昆明:云南大学出版社,1998:58.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部